DUBLIN–(BUSINESS WIRE)–The “Pharmacy Outsourcing Market Research Report by Service (Audit & Assessment, Consulting & Product Design & Development), End Use, Region (Americas, Asia-Pacific and Europe, Middle East and Africa) – Global forecast for 2027 – The report “Cumulative Impact of COVID-19” has been added to from ResearchAndMarkets.com offer.
The global pharmaceutical services outsourcing market size was estimated to be USD 67.99 billion in 2021, USD 72.66 billion in 2022, and is projected to grow at a CAGR of 7.12% to reach USD 102.75 billion. 2027.
Competitive Strategy Window:
The strategic competitive window analyzes the competitive landscape in terms of markets, applications and geographies to help the vendor define an alignment or match between its capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for vendors to adopt successive strategies of merger and acquisition, geographic expansion, research and development, and new product introduction strategies to execute further business expansion and growth. during a forecast period.
FPNV positioning matrix:
The FPNV Positioning Matrix evaluates and ranks vendors in the Pharmaceutical Services Outsourcing Market based on business strategy (business growth, industry coverage, financial viability, and channel support) and product satisfaction (value for money, ease of use, product features and customer). Support) that helps businesses make better decisions and understand the competitive landscape.
Market share analysis:
The market share analysis offers the analysis of the vendors considering their contribution to the overall market. It gives the idea of its revenue generation in the overall market compared to other providers in the space. It provides information on the performance of vendors in terms of revenue generation and customer base compared to others. Knowing the market share gives an idea of the size and competitiveness of suppliers for the reference year. It reveals market characteristics in terms of accumulation, fragmentation, dominance and melting traits.
The report provides information about the following pointers:
1. Market Penetration: Provides comprehensive information about the market offered by major players
2. Market Development: Provides detailed information on lucrative emerging markets and analyzes penetration in mature market segments
3. Market Diversification: Provides detailed information on new product launches, untapped geographies, recent developments and investments
4. Competitive Assessment and Intelligence: Provides a comprehensive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of key players
5. Product Development and Innovation: Provides smart insights into future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the global pharmaceutical services outsourcing market?
2. What are the inhibiting factors and impact of COVID-19 on the global pharmaceutical services outsourcing market during the forecast period?
3. What are the products/segments/applications/areas to invest in during the forecast period in the global pharmaceutical services outsourcing market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Services Outsourcing Market?
5. What are the technology trends and regulatory frameworks in the global pharmaceutical services outsourcing market?
6. What is the market share of the major vendors in the global pharmaceutical services outsourcing market?
7. What modes and strategic moves are considered suitable for entering the global pharmaceutical services outsourcing market?
Market dynamics
Drivers
-
Increase in pharmaceutical expenditure on research and development activities, mainly in oncology and automotive therapy
-
Potential need attributed to time and cost savings in the operations and management of a production and research facility
-
Growing demand from small pharmaceutical and biotech companies
Constraints
-
Reduced profit margins due to strong competition in the market
Opportunities
-
Emerging adoption of machine learning and artificial intelligence combined with automation in drug development
-
Significant investment in new and therapeutic therapies such as regenerative medicine
Challenges
-
Likely risks due to pending immigration laws in the United States and other countries
Companies cited
-
Cambrex Corporation
-
CareCloud, Inc.
-
Cerner Company
-
Charles River International Laboratories, Inc.
-
Citadel Outsourcing Group
-
Concept Heidelberg GmbH
-
eClinicalWorks
-
Eurofins Scientific
-
GMP Pharmaceuticals Pty Ltd.
-
PLC ICON
-
Inspired Pharma Formation Ltd.
-
IQVIA Inc.
-
Lachman Consulting Services, Inc.
-
NextGen Healthcare, Inc.
-
Parexel International Corporation
-
PRA Health Sciences
-
Quality Background Ltd.
-
Reading Scientific Services Ltd.
-
SGS S.A.
-
The quantum group
For more information about this report visit https://www.researchandmarkets.com/r/4uwocr
